To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2020

Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks

Vol: 9| Issue: 8| Number:10| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial

Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12455

Contributing Authors:
Z Malik L Bayman J Valestin A Rizvi-Toner S Hashmi R Schey

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirteen patients with non-cardiac functional chest pain were randomized to receive 5 mg capsules of dronabinol or placebo twice daily for 4 weeks. Patients described their chest pain episodes, completed the Short Form-36 (SF-36), Beck Anxiety Inventory and Beck Depression Inventory, and rated their pain during esophageal balloon distention tests (EBDT) to determine if dronabinol increased pain th...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue